Details of the Drug Reposition

General Information of This Drug (ID: DMKMCP8)

Drug Name
LEO 43204   DMKMCP8
Synonyms
ingenol disoxate; Ingenol disoxate; UNII-3B100VJ4ZW; 3B100VJ4ZW; 1383547-60-1; Ingenol disoxate [INN]; Ingenol disoxate [USAN:INN]; SCHEMBL16153426; CHEMBL3989918; LEO43204; 4-Isoxazolecarboxylic acid, 3,5-diethyl-, (1aR,2S,5R,5aS,6S,8aS,9R,10aR)-1a,2,5,5a,6,9,10,10a-octahydro-5,5a-dihydroxy-4-(hydroxymethyl)-1,1,7,9-tetramethyl-11-oxo-1H-2,8a-methanocyclopenta(a)cyclopropa(E)cyclodecen-6-yl ester
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Squamous cell carcinoma DISQVIFL 2B60-2D01 Phase 3 [1]
------------------------------------------------------------------------------------
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Acne vulgaris DISKW8PI ED80 Phase 2 [2]
Actinic keratosis DISR1RC5 EK90.0 Phase 2 [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)